A novel combination of serum microRNAs for the detection of early gastric cancer.

Authors:
Abe S; Matsuzaki J; Sudo K; Oda I; Katai H and 7 more

Journal:
Gastric Cancer

Publication Year: 2021

DOI:
10.1007/s10120-021-01161-0

PMCID:
PMC8205917

PMID:
33743111

Journal Information

Full Title: Gastric Cancer

Abbreviation: Gastric Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data sets analyzed in the study were submitted to the national center for biotechnology information gene expression omnibus database under accession number gse164174."

Code Sharing
Evidence found in paper:

"Conflict of interest Satoko Takizawa is an employee of Toray Industries, Inc., the provider of the 3D-Gene® system. The other authors have no conflicts of interest to declare."

Evidence found in paper:

"The study was supported by a “Development of Diagnostic Technology for Detection of miRNA in Body Fluids” grant from the Japan Agency for Medical Research and Development (to T.O.). The National Cancer Center Biobank is supported by the NCC Research and Development Fund (29-A-1). We thank Tomomi Fukuda, Takumi Sonoda, Hiroko Tadokoro, Megumi Miyagi, Tatsuya Suzuki, Jumpei Kawauchi, Makiko Ichikawa, and Kamakura Techno-Science Inc. for assistance with the microarray assays; Noriko Abe for management of the serum samples; Michiko Ohori for the management of personal information; and Yoshiaki Aoki and Hitoshi Fujimiya (Dynacom Co. Ltd) for developing in- house analytical tools."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025